Two main objectives were put forward at the meeting. One to ensure Hybiome’s goal of becoming the leading Chinese enterprise in the field of chemiluminescence immunoassay diagnostics and the other to achieve initial public offering and listing (IPO) within five years.
At the meeting, Alexandre Mérieux introduced the Biomérieux, it’s history and recent development to a worldwide leader in the IVD industry. By realizing the motto “In China, For China and With China”, Biomérieux has been actively devoted to help in the construction of China‘s Public Health Sector. Alexandre Mérieux said it has been his great pleasure to reach a cooperation with Hybiome and he believes the cooperation will help Hybiome to be more competitive in the Chinese IVD market. Biomérieux will do its utmost to support Hybiome to implement the jointly formulated 5-year Action Plan, so as to achieve the two objectives as early as possible.
On behalf of Suzhou Science and Technology Management Committee, Mr. Guorong Wang congratulated the participants for a very successful conference and spoke highly of the remarkable achievements Hybiome has had for 7 years. At the same time, he fully praised the five-year Action plan and the two objectives formulated jointly by Biomérieux and Hybiome. Mr. Wang stressed: the government will continue to provide help and support for the healthy growth of the enterprise. Will maximize the services and protection to Hybiome within the framework of the laws, regulations and policies to promote Hybiome’s rapid development.
Later, the representatives of Hybiome top management, sales, middle management and junior staff gave speeches. All of them expressed their active and positive attitudes towards the 5-year Action Plan and feel very confident with the company’s development, and are fully prepared and eager to grow together with the company.
Mr. Jianhua Dong looked back at Hybiome’s history, expressed gratitude and appreciation towards his team. Mr. Dong also expressed his pride for the achievements of Hybiome’s staff. He believes Biomérieux’s investment will further strengthen Hybiome’s development in future. Devoted to the Chinese populations health, he calls for all the employees to firmly unite and strive to implement Hybiome's 5-year Action Plan, realizing the Two main objectives:
Hybiome’s goal of becoming the leading Chinese enterprise in the field of chemiluminescence immunoassay diagnostics and Achieve initial public offering and listing (IPO) within five years.
Address: Block 4, No.8, Jinfeng Road, Suzhou, China